Page last updated: 2024-08-16

salmeterol xinafoate and Smoking Cessation

salmeterol xinafoate has been researched along with Smoking Cessation in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (57.14)	29.6817
2010's	3 (42.86)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Housset, B; Tillie-Leblond, I	1
Marchand, E	1
Baxter, N; Restrick, L; Stern, M	1
Goldman, CA; Goldman, MD; Robinson, EM	1
Anzueto, A	1
Beghé, B; Fabbri, LM; Luppi, F; Rabe, KF	1

Reviews

4 review(s) available for salmeterol xinafoate and Smoking Cessation

Article	Year
[Long-term trials assessing pharmacological treatments in COPD: lessons and limitations]. Revue des maladies respiratoires, 2010, Volume: 27, Issue:2 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Budesonide; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluticasone; Humans; Ipratropium; Long-Term Care; Male; Middle Aged; Prednisone; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide; Triamcinolone	2010
Something old, something new, something borrowed. COPD treatment today. Advance for nurse practitioners, 2006, Volume: 14, Issue:2 Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Anti-Inflammatory Agents; Beclomethasone; Bronchodilator Agents; Drug Monitoring; Ethanolamines; Exercise Tolerance; Forced Expiratory Volume; Formoterol Fumarate; Humans; Inflammation; Plethysmography, Whole Body; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide; Treatment Outcome	2006
Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions. The American journal of medicine, 2006, Volume: 119, Issue:10 Suppl 1 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Drug Therapy, Combination; Forced Expiratory Volume; Health Status; Humans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide	2006
Update in chronic obstructive pulmonary disease 2006. American journal of respiratory and critical care medicine, 2007, Jun-15, Volume: 175, Issue:12 Topics: Albuterol; Androstadienes; Bronchodilator Agents; Diagnostic Imaging; Fluticasone; Humans; Immunity, Innate; Muscle, Skeletal; Oxygen Inhalation Therapy; Pulmonary Disease, Chronic Obstructive; Respiratory Muscles; Salmeterol Xinafoate; Smoking Cessation	2007

Other Studies

3 other study(ies) available for salmeterol xinafoate and Smoking Cessation

Article	Year
[Debates surrounding COPD]. Revue des maladies respiratoires, 2010, Volume: 27, Issue:2 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Albuterol; Androstadienes; Anti-Inflammatory Agents; Breathing Exercises; Bronchodilator Agents; Combined Modality Therapy; Drug Therapy, Combination; Fluticasone; Humans; Oxygen Inhalation Therapy; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide	2010
Tiotropium versus salmeterol in COPD. The New England journal of medicine, 2011, 06-30, Volume: 364, Issue:26 Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Humans; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Smoking Cessation; Tiotropium Bromide	2011
[What are the options other than smoking cessation? Public health illness COPD calls in experts for the plan]. MMW Fortschritte der Medizin, 2001, May-17, Volume: 143, Issue:20 Topics: Albuterol; Bronchodilator Agents; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate; Smoking Cessation	2001